HealthPrize Technologies Enters Into Partnership with Walgreens on Adherence Platform

HealthPrize Technologies announced that its HealthPrize Action Engine patient engagement and medication adherence platform will be offered through Walgreens. The program is expected to finish development later this month. Once it is completed, it will be presented to pharmaceutical sponsors as a way to support patient adherence. It is planned to be offered to patients filling certain brand-name prescriptions for chronic conditions such as diabetes on Walgreens.com.

The HealthPrize Action Engine platform uses gamification, concepts from behavioral economics, and incentives redeemable at Walgreens to motivate patients to engage and learn about their condition and to remain adherent. For example, participating patients could be offered weekly condition-related quizzes and surveys, daily health tips and fun facts, leaderboards and competitions, daily medication prompts via email or SMS (at the patient’s option), monthly refill reminders, and medication adherence scorecards. The HIPAA-compliant program will also allow participating patients to track any of their other medications filled at Walgreens.

“We are pleased to be able to offer the HealthPrize platform to select Walgreens patients through this collaboration,” Tom Kottler, HealthPrize CEO and Co-founder, said in a statement. “This will also give healthcare brands an omni-channel approach to educating and motivating patients to take their medications and achieve improved health outcomes.”

The program is expected to launch with implementation from partners in Q3 2016 for diabetes. Then additional conditions such as GI, high cholesterol, depression, asthma, and COPD, will be added by the end of the year.

“We are continuing to innovate in digital health, enhancing our services and solutions to extend the basic care our pharmacists provide for our patients,” Greg Orr, Walgreens Boots Alliance Senior Director of Digital Health, said in a statement. “This platform gives us another opportunity to help improve patient adherence and outcomes, furthering our commitment to being a patient champion and partner of choice.”

Ads